Journal article

A role for galanin in human and experimental inflammatory demyelination

DC Wraith, R Pope, H Butzkueven, H Holder, P Vanderplank, P Lowrey, MJ Day, AL Gundlach, TJ Kilpatrick, N Scolding, D Wynick

Proceedings of the National Academy of Sciences of the United States of America | NATL ACAD SCIENCES | Published : 2009

Abstract

The neuropeptide galanin is widely expressed by many differing subsets of neurons in the nervous system. There is a marked upregulation in the levels of the peptide in a variety of nerve injury models and in the basal forebrain of humans with Alzheimer's disease. Here we demonstrate that galanin expression is specifically and markedly upregulated in microglia both in multiple sclerosis (MS) lesions and shadow plaques. Galanin expression is also upregulated in the experimental autoimmune encephalomyelitis (EAE) model of MS, although solely in oligodendrocytes. To study whether the observed increase in expression of galanin in inflammatory demyelination might modulate disease activity, we appl..

View full abstract

University of Melbourne Researchers

Grants

Awarded by National Institute on Aging


Funding Acknowledgements

We thank the Multiple Sclerosis Society Brain Bank (Charing Cross Hospital, London) for the generous provision of MS tissue. This work was supported by the Medical Research Council, The Wellcome Trust, National Institute on Aging (AG10668), the U.K. Multiple Sclerosis Society, the National Health Medical Research Council of Australia (454581 and 400476), and National Multiple Sclerosis Society Grant RG 3850A3/1.